Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.21.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2021
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

Assumptions:

 

    2021     2020  
Dividend yield     0.00 %     0.00 %
Risk-free interest rate     0.19-0.22 %     0.19-0.50 %
Expected volatility     116.8-117.2 %     116.0-117.0 %
Expected life (in years)     5       5  
Schedule of Stock Option Activity

Option activity for the three months ended March 31, 2021 and the year ended December 31, 2020 was as follows:

 

    Options     Weighted Average Exercise Price ($)     Weighted Average Remaining Contractual Life (Yrs.)     Aggregate Intrinsic Value ($)  
                         
Options outstanding at December 31, 2019     180,912       1.81       5.09       25,988  
Granted     579,998       2.55       4.57       -  
Exercised     -       -       -       -  
Forfeited or cancelled     (47,900 )     22.62       -       -  
Options outstanding at December 31, 2020     713,010       5.15       4.40       477,802  
Granted     143,072       3.21       4.77       -  
Exercised     -       -       -       -  
Forfeited or cancelled     -       -       -       -  
Options outstanding March 31, 2021     856,082       4.82       4.26       746,906  
Options expected to vest in the future as of March 31, 2021     439,611       3.73       4.40       -  
Options exercisable at March 31, 2021     416,471       5.98       4.10       -  
Options vested, exercisable, and options expected to vest at March 31, 2021     856,082       4.82       4.26       746,906  
Summary of Warrant Activity

Warrant activity for the three months ended March 31, 2021 the year ended December 31, 2020 was as follows:

 

    Warrants     Weighted Average Exercise Price ($)     Weighted Average Remaining Contractual Life (Yrs.)  
Warrants outstanding at December 31, 2019     363,728       25.60       3.12  
Granted     1,540,139       3.19       4.64  
Exercised     (22,438 )     -       -  
Forfeited or cancelled     -       -       -  
Warrants outstanding at December 31, 2020     1,881,429       7.57       4.16  
Granted     412,143       4.60       3.66  
Exercised     (495,641 )     2.59       -  
Forfeited or cancelled     -       -       -  
Warrants outstanding at March 31, 2021     1,797,931       8.26       3.72  
Stock Appreciation Rights [Member]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

Assumptions:

 

    2021     2020  
Dividend yield     0.00     0.00- %
Risk-free interest rate     0.19-0.22     0.19-0.22
Expected volatility     116.2%-116,8     116.2-116.8
Expected life (in years)     5       5  
Schedule of Stock Option Activity

SARs activity for the three months ended March 31, 2021 and the year ended December 31, 2020 was as follows:

 

    Options     Weighted Average Exercise Price ($)     Weighted Average Remaining Contractual Life (Yrs.)     Aggregate Intrinsic Value ($)  
                -        
SARs outstanding at December 31, 2019     -       -       -        
Granted     127,679       2.61       4.52       97,919  
Exercised     -       -       -       -  
Forfeited or cancelled     -       -       -       -  
SARs outstanding at December 31, 2020     127,679       2.61       4.52       97,919  
Granted     -       -       -       -  
Exercised     -       -       -       -  
Forfeited or cancelled     -       -       -       -  
SARs outstanding March 31, 2021     127,679       2.61       4.27       141,330  
SARs expected to vest in the future as of March 31, 2021     118,679       2.62       4.25       -  
SARs exercisable at March 31, 2021     9,000       2.47       4.64       -  
SARs vested, exercisable, and SARs expected to vest at March 31, 2021     127,679       2.61       4.27       141,330